CDRH Promotion/Advertising Merging With OC Under Reorganization Plan
This article was originally published in The Gray Sheet
Executive Summary
FDA's Center for Devices & Radiological Health plans to fold the Promotion & Advertising Policy Staff into the Office of Compliance
You may also be interested in...
FDA Approps Amendment Targets Chief Counsel Troy
FDA Chief Counsel Daniel Troy's intervention in civil suits on behalf of device maker Pacesetter and several drug firms has drawn a rebuke from House legislators in the form of funding cuts
FDA Approps Amendment Targets Chief Counsel Troy
FDA Chief Counsel Daniel Troy's intervention in civil suits on behalf of device maker Pacesetter and several drug firms has drawn a rebuke from House legislators in the form of funding cuts
Promotion & Advertising Policy Work Is On OC Agenda; Will PAPS Be Revived?
Device promotion and advertising policy development will be a key focus for CDRH's Office of Compliance during fiscal 2004, according to Director Timothy Ulatowski